Donna Sillman
Obstetrics & Gynecology · Philadelphia, PANPI 1841480282
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Among obstetrics & gynecology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 91 payments — averaging $35.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$531
- Novo Nordisk$431
- Astellas Pharma US Inc$382
- Amgen$248
- Lilly USA, LLC$180
- AbbVie$145
- plus $1K from 18 others
What the payments were for
- Speaking & faculty fees$150%
- Food & beverage$3,186100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 15 | $531 |
| Novo Nordisk | 9 | $431 |
| Astellas Pharma US Inc | 13 | $382 |
| Amgen | 3 | $248 |
| Lilly USA, LLC | 4 | $180 |
| AbbVie | 2 | $145 |
| Biohaven Pharmaceutical Holding Company Ltd. | 9 | $141 |
| Sumitomo Pharma America, Inc. | 1 | $125 |
| Xeris Pharmaceuticals, Inc. | 1 | $123 |
| Biogen | 1 | $120 |
| Mayne Pharma Commercial LLC | 1 | $104 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $94 |
| Pfizer | 4 | $91 |
| Exeltis, USA Inc. | 4 | $78 |
| Bayer | 4 | $75 |
| Merck | 4 | $69 |
| Therapeuticsmd, Inc. | 3 | $52 |
| Mylan Pharmaceuticals Inc. | 3 | $48 |
| Johnson & Johnson | 2 | $39 |
| Evofem Biosciences, Inc. | 2 | $38 |
| Organon | 1 | $34 |
| Avion Pharmaceuticals | 2 | $28 |
| Mckesson Medical-surgical, Inc. | 1 | $15 |
| Hologic Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,201 in reported general payments places this provider in the 90th percentile of 1,711 obstetrics & gynecology providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metronidazole | 27 | $888 |
| Fluconazole | 13 | $61 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Philadelphia
- Stephen KlaskoPhiladelphia$2.2M
- Stephanie SoberPhiladelphia$1.8M
- Jamille Nagtalon-RamosPhiladelphia$183K
- Matthew BesharaPhiladelphia$56K
- Karolynn EcholsPhiladelphia$38K
- Miriam RaffeldPhiladelphia$33K
- Dana ShanisPhiladelphia$33K
- Alex SorianoPhiladelphia$22K
- Dacarla AlbrightPhiladelphia$20K
- Rupsa BoeligPhiladelphia$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.